Host, Viral, and Environmental Transcriptome Profiles of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Abstract
The pandemic from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) led to hundreds of thousands of deaths, including >15,000 in New York City (NYC). This pandemic highlighted a pressing clinical and public health need for rapid, scalable diagnostics that can detect SARS-CoV-2 infection, interrogate strain evolution, and map host response in patients. To address these challenges, we designed a fast (30 minute) colorimetric test to identify SARS-CoV-2 infection and simultaneously developed a large-scale shotgun metatranscriptomic profiling platform for nasopharyngeal swabs. Both technologies were used to profile 338 clinical specimens tested for SARS-CoV-2 and 86 NYC subway samples, creating a broad molecular picture of the COVID-19 epidemic in NYC. Our results nominate a novel, NYC-enriched SARS-CoV-2 subclade, reveal specific host responses in ACE pathways, and find mediation risks associated with SARS-CoV-2 infection and ACE inhibitors. Our findings have immediate applications to SARS-CoV-2 diagnostics, public health monitoring, and therapeutic development.
Competing Interest Statement
N.T. and B.L. are employees at New England Biolabs.
Footnotes
Updated text for clarity and cleaned up Figure 1 and 5.
Subject Area
- Biochemistry (7346)
- Bioengineering (5323)
- Bioinformatics (20263)
- Biophysics (10016)
- Cancer Biology (7743)
- Cell Biology (11300)
- Clinical Trials (138)
- Developmental Biology (6437)
- Ecology (9951)
- Epidemiology (2065)
- Evolutionary Biology (13322)
- Genetics (9361)
- Genomics (12583)
- Immunology (7701)
- Microbiology (19021)
- Molecular Biology (7441)
- Neuroscience (41036)
- Paleontology (300)
- Pathology (1229)
- Pharmacology and Toxicology (2137)
- Physiology (3160)
- Plant Biology (6860)
- Synthetic Biology (1896)
- Systems Biology (5311)
- Zoology (1089)